IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BOSSI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.343
AS - Asia 8.245
EU - Europa 4.420
SA - Sud America 2.020
AF - Africa 183
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 4
Totale 29.237
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.095
SG - Singapore 2.730
CN - Cina 1.926
HK - Hong Kong 1.848
BR - Brasile 1.737
UA - Ucraina 881
VN - Vietnam 635
DE - Germania 563
IT - Italia 547
IE - Irlanda 385
PL - Polonia 385
TR - Turchia 373
RU - Federazione Russa 361
GB - Regno Unito 331
EE - Estonia 295
FI - Finlandia 211
IN - India 162
AR - Argentina 127
CA - Canada 116
ID - Indonesia 116
SE - Svezia 107
BD - Bangladesh 95
AT - Austria 78
MX - Messico 75
ZA - Sudafrica 73
IQ - Iraq 70
FR - Francia 69
EC - Ecuador 49
PK - Pakistan 45
NL - Olanda 42
CZ - Repubblica Ceca 40
ES - Italia 37
JP - Giappone 36
SA - Arabia Saudita 36
EG - Egitto 34
CO - Colombia 26
PY - Paraguay 23
MA - Marocco 22
UZ - Uzbekistan 22
VE - Venezuela 21
AU - Australia 19
JO - Giordania 19
KE - Kenya 15
MY - Malesia 15
CH - Svizzera 14
NP - Nepal 14
PE - Perù 14
IL - Israele 13
AZ - Azerbaigian 12
BE - Belgio 12
CL - Cile 10
DO - Repubblica Dominicana 10
IR - Iran 10
AE - Emirati Arabi Uniti 9
JM - Giamaica 9
LT - Lituania 9
TN - Tunisia 9
CR - Costa Rica 8
DZ - Algeria 7
KZ - Kazakistan 7
OM - Oman 7
UY - Uruguay 7
AL - Albania 6
BH - Bahrain 6
HR - Croazia 6
LB - Libano 6
MK - Macedonia 6
NI - Nicaragua 6
PA - Panama 6
ET - Etiopia 5
HN - Honduras 5
LY - Libia 5
SN - Senegal 5
DK - Danimarca 4
EU - Europa 4
GR - Grecia 4
KG - Kirghizistan 4
KR - Corea 4
LK - Sri Lanka 4
PH - Filippine 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
KW - Kuwait 3
MU - Mauritius 3
PT - Portogallo 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
GY - Guiana 2
IS - Islanda 2
LU - Lussemburgo 2
MD - Moldavia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
AM - Armenia 1
Totale 29.215
Salva come PNG Salva come JPEG
Città #
Fairfield 2.231
Hong Kong 1.839
Ashburn 1.437
Singapore 1.148
Seattle 919
Woodbridge 898
Jacksonville 848
Houston 788
Cambridge 694
Wilmington 674
Princeton 636
Beijing 520
Dallas 448
New York 420
Chandler 416
Warsaw 378
The Dalles 374
Dublin 342
Istanbul 319
Tallinn 295
Ann Arbor 282
Los Angeles 244
Ho Chi Minh City 185
Des Moines 170
Nanjing 163
Redondo Beach 151
San Diego 151
Helsinki 140
São Paulo 135
Hanoi 124
Buffalo 120
Brescia 112
Moscow 102
Munich 97
London 90
Jakarta 83
Chicago 81
Changsha 74
Shenyang 73
Nuremberg 72
Shanghai 69
San Francisco 68
Milan 59
Dong Ket 58
Jinan 58
Tianjin 58
Nanchang 57
Hebei 52
Brooklyn 51
Jiaxing 51
Johannesburg 44
Menlo Park 43
Santa Clara 43
Pune 41
Belo Horizonte 38
Rio de Janeiro 38
Rome 37
Turku 37
Guangzhou 36
Toronto 35
Brno 33
Vienna 33
Brasília 32
Frankfurt am Main 32
Montreal 31
Tokyo 31
Curitiba 30
Salt Lake City 30
Haiphong 28
Lappeenranta 27
Ningbo 27
Campinas 26
Denver 26
Kilburn 26
Chennai 25
Hangzhou 24
Boston 23
Da Nang 23
Salvador 23
Norwalk 22
Phoenix 22
Zhengzhou 22
Atlanta 21
Poplar 21
Taizhou 21
Baghdad 20
Council Bluffs 20
Stockholm 20
Boardman 19
Cairo 19
Guayaquil 19
Santo André 19
Amman 18
Erbil 18
Manchester 18
Mexico City 18
Romola 18
Tashkent 18
New Delhi 17
Porto Alegre 17
Totale 20.183
Salva come PNG Salva come JPEG
Nome #
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck 798
Systematic review of photobiomodulation for the managementof oral mucositis in cancer patients and clinical practice guidelines 275
Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements. 210
Prognostic Nomograms in Oral Squamous Cell Carcinoma: The Negative Impact of Low Neutrophil to Lymphocyte Ratio 208
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 200
The 8th TNM classification for oral squamous cell carcinoma: What is gained, what is lost, and what is missing 197
Pretreatment DWI with Histogram Analysis of the ADC in Predicting the Outcome of Advanced Oropharyngeal Cancer with Known Human Papillomavirus Status Treated with Chemoradiation 197
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 192
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 166
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 162
Tumor biomarkers for the prediction of distant metastasis in head and neck squamous cell carcinoma 161
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus 157
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 154
Malignant tumors of the maxillary sinus: Prognostic impact of neurovascular invasion in a series of 138 patients 152
Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm? 152
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact 149
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN) 148
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 143
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 142
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial 142
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 140
Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma 139
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy 139
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus 133
Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents 133
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 130
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma 128
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients 124
Precision medicine in rare tumors and the need for multicenter trials and international collaboratives: Sinonasal cancer as paradigm 124
Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor 122
Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis 122
Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs) 120
Investigational drugs for head and neck cancer 120
Safety and feasibility of every-other-week maintenance cetuximab after first-line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancer 119
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin 119
The role of systemic therapy in the management of sinonasal cancer: A critical review 116
Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review 115
CISPLATIN DOSE INTENSITY CORRELATES WITH OUTCOME IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA RECEIVING CONCURRENT CISPLATIN BASED CHEMORADIATION: A MULTI-INSTITUTIONAL EXPERIENCE 115
Hope in cancer patients: the relational domain as a crucial factor 115
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 115
A European survey on the practice of nutritional interventions in head–neck cancer patients undergoing curative treatment with radio(chemo)therapy 115
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis 114
A ct-based radiomic signature can be prognostic for 10-months overall survival in metastatic tumors treated with nivolumab: An exploratory study 114
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma 113
Assessing Preferences in Patients with Head and Neck Squamous Cell Carcinoma: Phase I and II of Questionnaire Development 113
Receptor tyrosine kinase profiles and human papillomavirus status in oropharyngeal squamous cell carcinoma 112
A NATURAL HISTORY OF A SERIES OF RADIOACTIVE IODINE (131I-RAI)-RESISTANT ADVANCED DIFFERENTIATED THYROID CANCER (DTC) 111
Mining of self-organizing map gene-expression portraits reveals prognostic stratification of HPV-positive head and neck squamous cell carcinoma 111
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers 110
Multikinase inhibitors in thyroid cancer 110
Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma 109
Feasibility and activity of docetaxel, cisplatinum and 5-fluorouracil induction chemotherapy followed by concurrent chemo-radiotherapy (including IMRT) in locally advanced undifferentiated nasopharyngeal cancer (LANPC) 109
Not all hematopoietic growth factors are created equal: Should we gain information for their use with immunotherapy? 109
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study 108
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results 108
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis 107
Italian version of the MD Anderson Symptom Inventory-Head and Neck Module: linguistic validation 106
Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy 106
The Case Volume Issue in Head and Neck Oncology 106
Prolonged response using gefitinib followed by sirolimus for advanced cutaneous squamous cell carcinoma 105
Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area 105
TP53 Mutations and Pathologic Complete Response to Neoadjuvant Cisplatin and Fluorouracil Chemotherapy in Resected Oral Cavity Squamous Cell Carcinoma 105
Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab 105
Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area 105
Gastrointestinal toxicities from targeted therapies: measurement, duration and impact 105
NICSO: Network Italiano Cure di Supporto in Oncologia - Italian Network for Supportive Care in Oncology 105
Primary resistances to EGFR inhibitors (EGFRi) in HPV-positive and -negative oropharyngeal squamous cell carcinoma (OSCC) 105
New insights in chemotherapy 104
Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements 104
Nausea and vomiting during the first 3 intercycle periods in chemo-naive cancer patients receiving moderately/highly emetogenic therapy 104
Folate in head and neck squamous cell cancer chemoprevention: Purposely left out? 103
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients 103
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study 103
Regional disease in head and neck cutaneous squamous cell carcinoma: the role of primary tumor characteristics and number of nodal metastases 103
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 103
Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma 102
Differential impact of cisplatin dose intensity on human papillomavirus (HPV)-related (+) and HPV-unrelated (-) locoregionally advanced head and neck squamous cell carcinoma (LAHNSCC) 102
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy 102
Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data 102
Advanced lung cancer inflammation index and its prognostic value in HPV-negative head and neck squamous cell carcinoma: a multicentre study 102
Gene-expression profiles of primary and metastatic lesions in head and neck squamous cell carcinoma 101
Optimizing approaches to head and neck cancer. Metastatic head and neck cancer: new options 101
TP53 mutations in head and neck cancer 101
The Benefit of a Multidisciplinary Approach to the Patient Treated with (Chemo) Radiation for Head and Neck Cancer 101
Radiotherapy for unresectable sinonasal cancers: Dosimetric comparison of intensity modulated radiation therapy with coplanar and non-coplanar volumetric modulated arc therapy 100
Searching for Evidence to Support the Use of Ginger in the Prevention of Chemotherapy-Induced Nausea and Vomiting 100
Resistance to Hedgehog inhibitor through Smoothened receptor mutation in basal cell carcinoma 100
Pain related to cancer treatments and diagnostic procedures: a no man's land? 100
Emerging tyrosine kinase inhibitors for head and neck cancer 100
Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations 99
Dissecting heterogeneity and molecular mechanisms involved in paranasal sinus cancer 99
Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients 99
Isolating p16-positive/HPV-negative Oropharyngeal Cancer: An Effort Worth Making 99
Receptor Tyrosine Kinase Profiles and Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma 99
Induction chemotherapy within a multimodality treatment of nasal cavity and ethmoid sinus malignant epithelial tumours: report of an homogeneous series of patients 99
A complete remission with androgen-deprivation therapy in a recurrent androgen recptor-expressing adenocarcinoma of the parotid gland [1] 99
Comments on "Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: Patterns of failure" by Chan and Coll 98
Prognostic role of PI3KCA and TP53 in HPV-negative oropharyngeal cancers (OPCs) 98
Global cancer control: responding to the growing burden, rising costs and inequalities in access 98
Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up 98
Totale 12.850
Salva come PNG Salva come JPEG
Categoria #
all - tutte 185.781
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 185.781
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.116 0 0 0 0 0 729 152 519 345 723 284 364
2021/20222.337 116 253 56 283 109 212 76 202 120 195 201 514
2022/20231.518 359 89 46 113 92 464 8 96 144 26 37 44
2023/20242.385 64 36 117 107 122 577 90 137 665 39 33 398
2024/20255.799 32 21 69 1.028 543 536 336 134 730 555 1.132 683
2025/20267.726 1.063 2.379 1.309 1.712 773 490 0 0 0 0 0 0
Totale 29.648